Ovid Technologies, Inc. and
Kluwer Academic Publishers (KAP) have announced the addition of five Kluwer
academic medical journal titles to Journals@Ovid. The five journals join
a growing list of almost 400 electronic full-text journal titles in Ovid’s
aggregated electronic full-text database, which is available exclusively
via Ovid Online. Ovid will begin offering the journals via Journals@Ovid
this spring, beginning with the January 2000 issues.
“Adding these important medical journals to Journals@Ovid creates an
additional outlet for these titles next to our own Kluwer Online platform.
This is in line with our strategy to continuously develop ways and opportunities
to make our content available worldwide in an efficient and timely manner
to the researcher,” said Caroline Vogelzang, vice president of commercial
services for Kluwer Academic Publishers in Dordrecht, Netherlands.
“We are very pleased that Kluwer Academic has decided to aggregate these
five important journals with Ovid,” said Leslie Hawke, Ovid’s associate
director of publisher relations. “Our aggregated model lets end-users search
hundreds of medical journals from multiple publishers together, in one
database and with one interface. When we add key titles like these, we
obviously make Journals@Ovid more valuable to the researcher, but we also
increase the value of the individual journals.”
The five KAP titles being added to Journals@Ovid are as follows:
Annals of Oncology—The official journal of the European Society
for Medical Oncology
Breast Cancer Research and Treatment—A key source of communication
for presenting pertinent treatment of and investigations in breast cancer
Cardiovascular Drugs and Therapy—An authoritative source of current
and relevant news for cardiologists
Journal of Inherited Metabolic Disease—The official journal of the
Society for the Study of Inborn Errors of Metabolism
Journal of Neuro-Oncology—A multidisciplinary journal encompassing
basic, applied, and clinical investigations in all research areas as they
relate to cancer and the central nervous system
Source: Ovid Technologies, Inc., New York, 800/950-2035, 212/563-3006;
Fax: 212/563-3784; http://www.ovid.com.
Table
of Contents